Table 8.
Course No. | Time† | No. of Patients‡ | Mean CRP§ | SD|| | P¶ |
---|---|---|---|---|---|
1 | Pretreatment | 20 | 2.4 | 4.87 | |
After 2 doses | 16 | 14.9 | 4.95 | .0005 | |
After 3 doses | 19 | 9.9 | 3.86 | .0003 | |
After 1 week | 17 | 3.3 | 4.27 | .16 | |
After 3 weeks | 16 | 2.6 | 6.22 | .46 | |
2 | Pretreatment | 9 | 1.9 | 4.57 | |
After 2 doses | 10 | 13.3 | 6.18 | .009 | |
After 3 doses | 8 | 9.9 | 3.68 | .02 | |
After 1 week | 8 | 2.9 | 3.27 | .41 | |
After 3 weeks | 6 | 0.7 | 0.52 | 1.00 |
Abbreviations: CRP, C-reactive protein; SD, standard deviation.
CRP levels were monitored for patients 13 through 33 (dose levels 3.2 to 7.5 mg/m2/d).
Samples were obtained pretreatment (day 0 or 1), after two doses (day 3), after three doses (day 4 or 5), after 1 week (day 8 or 9) and after 3 weeks (day 22 or 23).
Number of patients for whom C-reactive protein data are available at each time point.
Mean CRP (mg/dL).
Standard deviation.
P value when compared to day 0, 1.